No black box warning on record for Tecvayli

As of the latest FDA labeling reviewed, Tecvayli (TECLISTAMAB-CQYV) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tecvayli medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hepatotoxicity : Can cause hepatotoxicity, including fatalities. Monitor liver enzymes and bilirubin at baseline and during treatment as clinically indicated. Withhold TECVAYLI or consider permanent discontinuation of TECVAYLI based on severity ( 2.5 , 5.4 ) Infections : Can cause severe, life-threatening, or fatal infections. Monitor patients for signs and symptoms of i

No black box warning on record for Tecvayli

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hepatotoxicity : Can cause hepatotoxicity, including fatalities. Monitor liver enzymes and bilirubin at baseline and during treatment as clinically indicated. Withhold TECVAYLI or consider permanent discontinuation of TECVAYLI based on severity ( 2.5 , 5.4 ) Infections : Can cause severe, life-threatening, or fatal infections. Monitor patients for signs and symptoms of i

Tecvayli Black Box Warning

No black box warning on record for Tecvayli

Other warnings & precautions

Tecvayli Black Box Warning

No black box warning on record for Tecvayli

Other warnings & precautions